Rolf Classon joins EKR'sboard as chairman
This article was originally published in Scrip
EKR Therapeutics, a privately held speciality pharmaceutical company providing critical care products to hospitals, has appointed Rolf Classon chairman of the board. He currently serves as director of Auxilium Pharmaceuticals, Hill-Rom Holdings, Tecan Group, Prometheus Laboratories and Fresenius Medical Care.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.